原文: 配制方法：准确称取一定量的CMC-Na粉末，用量筒量取一定体积的纯水转移至烧杯中，将CMC-Na粉末均匀分散在烧杯中，加入搅拌子，用磁力搅拌器搅拌至完全溶解，即得0.5 % CMC-Na溶液。

译文: Preparation method: Accurately weigh a certain amount of CMC-Na powder, use a measuring cylinder to measure a certain volume of pure water and transfer it to a beaker, uniformly disperse the CMC-Na powder in the beaker, add a stirring rod, and stir with a magnetic stirrer until completely dissolved, resulting in a 0.5% CMC-Na solution.
------------------------------------------------------------------------------------
原文: 名称/代号：sbk002；

译文: Name/Code: sbk002;
------------------------------------------------------------------------------------
原文: 6.2.	撰写流程	22

译文: 6.2.	Writing Process	22
------------------------------------------------------------------------------------
原文: 样品名

译文: Sample Name
------------------------------------------------------------------------------------
原文: 试验目的

译文: Study Objective
------------------------------------------------------------------------------------
原文: 拖尾因子（T）：T ≤ 2。

译文: Tailing factor (T): T ≤ 2.
------------------------------------------------------------------------------------
原文: 试验主要组成人员

译文: Assay main personnel
------------------------------------------------------------------------------------
原文: 称取约10 mg sbk002-D（含量：99.6 %），以稀释液1溶解并定容至10 mL，配制成浓度约为1 mg/mL的质控储备液（浓度 = 称取量 × 含量/体积）。命名为：配制日期-ST2-sbk，例如：180101-ST2-sbk。

译文: Accurately weigh approximately 10 mg sbk002-D (content: 99.6%), dissolve in diluent 1 and dilute to a volume of 10 mL, to prepare a quality control stock solution with a concentration of about 1 mg/mL (concentration = amount weighed × content/volume). Name it as: preparation date-ST2-sbk, for example: 180101-ST2-sbk.
------------------------------------------------------------------------------------
原文: 给药 制剂（μL）

译文: Dose formulation (μL)
------------------------------------------------------------------------------------
原文:                                                                          专题编号：A2018030-FA01

译文:                                                                          Study number: A2018030-FA01
------------------------------------------------------------------------------------
原文: 预计试验结束日期：2018-12-06。

译文: Estimated assay end date: 2018-12-06.
------------------------------------------------------------------------------------
原文: Wash（90 % 甲醇水溶液）：量取450 mL甲醇加至50 mL灭菌注射用水中，超声脱气泡15 min，即得。室温保存，有效期1个月。

译文: Wash（90 % 甲醇水溶液）：量取450 mL甲醇加至50 mL灭菌注射用水中，超声脱气泡15 min，即得。室温保存，有效期1个月。
------------------------------------------------------------------------------------
原文: 李萍                                                                         日期

译文: Li Ping                                                                         Date
------------------------------------------------------------------------------------
原文: 纯水

译文: Pure Water
------------------------------------------------------------------------------------
原文: 供试品制剂色谱分析方法学验证

译文: Test article formulation chromatography method validation
------------------------------------------------------------------------------------
原文: 系统

译文: System
------------------------------------------------------------------------------------
原文: 成都施贝康生物医药科技有限公司

译文: Chengdu Shibeikang Biotechnology Co., Ltd.
------------------------------------------------------------------------------------
原文: 7.3.	保存场所与保存条件	22

译文: 7.3.	Storage location and conditions	22
------------------------------------------------------------------------------------
原文: 质量保证

译文: Quality assurance
------------------------------------------------------------------------------------
原文: 研究机构和委托单位的名称、地址和联系方式；

译文: Test facility and sponsor's name, address, and contact information;
------------------------------------------------------------------------------------
原文: 1.6.	质量保证人员	7

译文: 1.6.	Quality assurance personnel	7
------------------------------------------------------------------------------------
原文: 有效期至：2020-08-07；

译文: Expiry date: 2020-08-07;
------------------------------------------------------------------------------------
原文: 给药制剂配制：刘露露、韩月、石鑫鑫；

译文: Dose formulations preparation: Liu Lulu, Han Yue, Shi Xinxin;
------------------------------------------------------------------------------------
原文: 配制日期-WS2-sbk

译文: Preparation date-WS2-sbk
------------------------------------------------------------------------------------
原文: 试验方案签字页

译文: Study protocol signature page
------------------------------------------------------------------------------------
原文: 各溶液等可根据实际需要和相应配制比例调整配制体积。未注明有效期的溶液等（除给药制剂外）均为现配现用。将首次配制标准曲线样品的日期定义为第一天（Day1/D1），以此类推至第n 天（Day n/Dn）。

译文: Each solution can be adjusted in preparation volume based on actual needs and corresponding preparation ratios. Solutions without specified expiry dates (except dose formulations) are prepared and used immediately. The date of the first preparation of the standard curve sample is defined as the first day (Day 1/D1), and so on to day n (Day n/Dn).
------------------------------------------------------------------------------------
原文: 稀释液1（乙腈）：分取200 mL 乙腈，即得。室温保存，有效期1个月。

译文: Diluent 1 (Acetonitrile): Measure 200 mL Acetonitrile to obtain the solution. Store at room temperature, valid for 1 month.
------------------------------------------------------------------------------------
原文: 色谱柱的管理、使用与维护

译文: Chromatographic column management, use and maintenance
------------------------------------------------------------------------------------
原文: 注：给药制剂设计浓度为例值，以最终配制时实际浓度为准。

译文: Note: Dose formulations design concentrations are example values, with the actual concentration at the time of final preparation considered as standard.
------------------------------------------------------------------------------------
原文: 专题负责人和参加试验的人员姓名和承担的工作；

译文: Study director and personnel participating in the assay's name and responsibilities;
------------------------------------------------------------------------------------
原文: 注：以上人员如有变动，具体信息在原始记录和总结报告中如实体现。

译文: Note: If there is any personnel change, the specific information will be accurately reflected in the raw record and final report.
------------------------------------------------------------------------------------
原文: 试验结果、讨论/结论；

译文: Assay results, discussion/conclusion;
------------------------------------------------------------------------------------
原文: 设计浓度    （mg/mL）

译文: Design concentration    (mg/mL)
------------------------------------------------------------------------------------
原文: 本试验将遵循的法规及技术指导原则，包括但不限于：

译文: This assay will comply with regulations and technical guidance principles, including but not limited to:
------------------------------------------------------------------------------------
原文: 保存场所：苏州华测生物技术有限公司档案管理部；

译文: Storage location: Suzhou Huace Biological Technology Co., Ltd. Archives Management Department;
------------------------------------------------------------------------------------
原文: 本人已理解该试验所依从各GLP法规的相关要求，并已对该研究机构进行评估；确保所提供的供试品和/或对照品的特性信息真实、准确同时也告知了该研究机构本研究供试品和/或对照品的相关安全信息。

译文: I have understood the relevant requirements of various GLP regulations that this assay adheres to and have evaluated the test facility; ensured that the characteristics information of the provided test article and/or reference item is true and accurate and have also informed the test facility of the related safety information of the test article and/or reference item in this study.
------------------------------------------------------------------------------------
原文: 名称：sbk002-D；

译文: Name: sbk002-D;
------------------------------------------------------------------------------------
原文: 分析方法

译文: Analyzed method
------------------------------------------------------------------------------------
原文: 准确度均应在95 % ~ 105 %之间，精密度RSD ≤ 5 %（n ≥ 3时需求算RSD）。

译文: Accuracy should be between 95% ~ 105%, precision RSD ≤ 5% (when n ≥ 3, RSD needs to be calculated).
------------------------------------------------------------------------------------
原文: 《非临床安全性评价供试品检测要求的Q&A》（原CFDA，2014年05月）；

译文: 《Non-clinical Safety Evaluation Test Article Testing Requirement Q&A》(Former CFDA, May 2014);
------------------------------------------------------------------------------------
原文: 数据整理及统计分析：王晓彤、陆明敏。

译文: Data collation and statistical analysis: Wang Xiaoxing, Lu Mingmin.
------------------------------------------------------------------------------------
原文: 注：若试验中用到其他批号参考品，相关信息需在原始记录及总结报告中如实记录及体现，以总结报告为准。

译文: Note: If other batch number reference products are used in the assay, relevant information needs to be accurately recorded and reflected in the original record and final report, with the final report as the standard.
------------------------------------------------------------------------------------
原文: 总结报告

译文: Final report
------------------------------------------------------------------------------------
原文: 定容   体积（mL）

译文: Dilute to volume   Volume (mL)
------------------------------------------------------------------------------------
原文: 吸取上述储备液（配制日期-ST1-clo）约1 mL，用稀释液2定容至10 mL，得浓度为100 μg/mL的标曲工作溶液，命名为：配制日期-WS1-clo，例如：180101-WS1-clo。

译文: Aspirate approximately 1 mL of the above stock solution (preparation date-ST1-clo), dilute to volume with 2 mL methanol to 10 mL, obtaining a working solution with a concentration of 100 µg/mL, named preparation date-WS1-clo, for example, 180101-WS1-clo.
------------------------------------------------------------------------------------
原文: 稀释液的配制

译文: Preparation of methanol solution
------------------------------------------------------------------------------------
原文: 峰面积和保留时间的RSD ≤ 2 %；

译文: Peak area and retention time RSD ≤ 2%;
------------------------------------------------------------------------------------
原文: 给药制剂分析方法学验证试验

译文: Dose formulations analyzed methodology validation assay
------------------------------------------------------------------------------------
原文: 注：以上人员如有变动，具体信息总结报告中如实体现。

译文: Note: If any of the above personnel changes, detailed information will be accurately reflected in the final report.
------------------------------------------------------------------------------------
原文: 委托单位

译文: Sponsor
------------------------------------------------------------------------------------
原文: 性状：类白色结晶性粉末；

译文: Characterization: off-white crystalline powder;
------------------------------------------------------------------------------------
原文: 甲醇

译文: Methanol
------------------------------------------------------------------------------------
原文: 方法学验证

译文: Methodology validation
------------------------------------------------------------------------------------
原文: 7.2.	归档内容	22

译文: 7.2.	Archived Data	22
------------------------------------------------------------------------------------
原文: 供试品

译文: Test article
------------------------------------------------------------------------------------
原文: 吸取量       （μL）

译文: Aspirating volume       (µL)
------------------------------------------------------------------------------------
原文: 方法学验证测定序列

译文: Methodology validation determination sequence
------------------------------------------------------------------------------------
原文: 数据采集和分析

译文: Data acquisition and analysis
------------------------------------------------------------------------------------
原文: 主要研究相关的SOP

译文: Related SOP for main research
------------------------------------------------------------------------------------
原文: 标准曲线线性范围

译文: Standard Curve linear range
------------------------------------------------------------------------------------
原文: 称取约10 mg clo（含量：99.75 %），以稀释液1溶解并定容至10 mL，配制成浓度约为1 mg/mL的标曲储备液（浓度 = 称取量 × 纯度/体积）。命名为：配制日期-ST1-clo，例如：180101-ST1-clo。

译文: Accurately weigh about 10 mg of clo (content: 99.75%), dissolve in 1 mL methanol and dilute to volume to 10 mL, preparing a stock solution with a concentration of approximately 1 mg/mL (concentration = weight × purity/volume). Named as: preparation date-ST1-clo, for instance, 180101-ST1-clo.
------------------------------------------------------------------------------------
原文: 分析测试部标准物质的接收、保存、取用及处置

译文: Analytical Testing Department's Reference Standard reception, storage, retrieval, and handling
------------------------------------------------------------------------------------
原文: 3.2.	方法学验证测定序列	16

译文: 3.2.	Methodology validation determination sequence	16
------------------------------------------------------------------------------------
原文: 在第二个分析批中运行第一个分析批的sbk002组和clo组给药制剂配制的其中3份准确度与精密度样品（室温遮光放置至少12 h）。命名为：STA(Post)_A_1 、 STA(Post)_A_3、STA(Post)_A_5、STA(Post)_B_1 ~ STA(Post)_B_3和STA(Post)_B_5。

译文: In the second analytical run, run samples from the first analytical run for sbk002 group and clo group dose formulations preparation, ensuring 3 samples for accuracy and precision (stored at room temperature under shading for at least 12 h). Named as: STA(Post)_A_1, STA(Post)_A_3, STA(Post)_A_5, STA(Post)_B_1 ~ STA(Post)_B_3, and STA(Post)_B_5.
------------------------------------------------------------------------------------
原文: 将待测制剂按给药制剂取样和处理方法进行处理后，进样分析。不同天重复测定至少三个分析批，以当批的标准曲线计算样品的浓度，并以此求算方法的准确度和精密度。命名为： AP_A_1 ~ AP_A_6和AP_B_1 ~  AP_B_6。

译文: Perform sampling and processing of the formulations according to the prescribed dosage forms. After treatment, analyze the samples. Conduct at least three analytical runs on different days to calculate the sample concentration using the standard curve of the batch, and thereby determine the accuracy and precision of the calculation method. These are named as: AP_A_1 ~ AP_A_6 and AP_B_1 ~ AP_B_6.
------------------------------------------------------------------------------------
原文: 定量下限

译文: lower limit of quantification
------------------------------------------------------------------------------------
原文: 6.1.	报告拟记载的主要内容	21

译文: 6.1.	The main contents reported	21
------------------------------------------------------------------------------------
原文: 给药制剂的配制

译文: preparation of dose formulations
------------------------------------------------------------------------------------
原文: 准确称取12.5 g的sbk002至研钵中，用0.5 % CMC-Na溶液充分研磨后，完全转移至标定体积（50 mL）的容器中，用0.5 % CMC-Na定至刻度，即得250 mg/mL的sbk002组给药制剂。

译文: Accurately weigh 12.5 g of sbk002 into the grinding mortar, use 0.5% CMC-Na solution for thorough grinding, completely transfer into a calibrated volume (50 mL) container, and adjust to the volume with 0.5% CMC-Na solution to prepare a 250 mg/mL solution of sbk002 dosage formulation.
------------------------------------------------------------------------------------
原文: 系统适应性

译文: System Suitability
------------------------------------------------------------------------------------
原文: 《药物非临床研究质量管理规范》（原CFDA，2017年09月）；

译文: 《Good Laboratory Practices (GLPs) for Non-clinical Laboratory Studies》 (Former CFDA, September 2017);
------------------------------------------------------------------------------------
原文: GLP依从性声明和质量保证声明；

译文: Statement of GLP Compliance and Quality Assurance;
------------------------------------------------------------------------------------
原文: 定容  体积（mL）

译文: dilute to volume  volume (mL)
------------------------------------------------------------------------------------
原文: 电话：028-62532315；

译文: Telephone: 028-62532315;
------------------------------------------------------------------------------------
原文: 偏离的处理

译文: Handling of Deviations
------------------------------------------------------------------------------------
原文: 配制方法

译文: preparation method
------------------------------------------------------------------------------------
原文: 撰写流程

译文: Writing Process
------------------------------------------------------------------------------------
原文: 配制条件：室温、避光环境下；

译文: Preparation conditions: room temperature, protected from excessive light;
------------------------------------------------------------------------------------
原文: 配制日期-WS1-clo

译文: preparation date-WS1-clo
------------------------------------------------------------------------------------
原文: 主要仪器

译文: Major Instruments
------------------------------------------------------------------------------------
原文: 系统残留

译文: Carry-over
------------------------------------------------------------------------------------
原文: 准确度与      精密度

译文: accuracy      precision
------------------------------------------------------------------------------------
原文: 色谱柱：ACQUITY UPLC® BEH C18 1.7 μm 2.1 mm × 50 mm；

译文: Chromatographic column: ACQUITY UPLC® BEH C18 1.7 μm 2.1 mm × 50 mm;
------------------------------------------------------------------------------------
原文: 试剂和溶液的管理和使用总则

译文: General rules for management and use of reagents and solutions
------------------------------------------------------------------------------------
原文: 名称：苏州华测生物技术有限公司；

译文: name: Suzhou Huace Bioscience Technology Co., Ltd.;
------------------------------------------------------------------------------------
原文: 委托方签字页	3

译文: Sponsor signature page	3
------------------------------------------------------------------------------------
原文: 邮编：611731；

译文: Postal code: 611731;
------------------------------------------------------------------------------------
原文: 批号：180802；

译文: batch number: 180802;
------------------------------------------------------------------------------------
原文: 联系人：牟霞；

译文: Contact person: 毛霓;
------------------------------------------------------------------------------------
原文: 1.2.	试验目的	6

译文: 1.2.	Study Objective	6
------------------------------------------------------------------------------------
原文: 试验方法

译文: assay method
------------------------------------------------------------------------------------
原文: 1.4.	委托单位	6

译文: 1.4.	Sponsor	6
------------------------------------------------------------------------------------
原文: 剩余参考品处理：退回委托方。

译文: Disposal of remaining reference substances: Return to the sponsor.
------------------------------------------------------------------------------------
原文: 有机相（乙腈）：乙腈，超声脱气泡15 min，即得。室温保存，有效期1个月。

译文: Organic phase (Acetonitrile): Acetonitrile, sonicate to remove bubbles for 15 min, then obtain. Store at room temperature, valid for 1 month.
------------------------------------------------------------------------------------
原文: 专题编号：A2018030-FA01。

译文: study number: A2018030-FA01.
------------------------------------------------------------------------------------
原文: 型号

译文: Model
------------------------------------------------------------------------------------
原文: 试验方案签字页	2

译文: study protocol signature page	2
------------------------------------------------------------------------------------
原文: 苏州华测生物技术有限公司

译文: Suzhou Huace Bioscience Technology Co., Ltd.
------------------------------------------------------------------------------------
原文: 保存条件：常规；

译文: Storage conditions: routine;
------------------------------------------------------------------------------------
原文: 水相（0.2 % TFA水溶液）：量取400 μL TFA加至200 mL灭菌注射用水中，混匀后，超声脱气泡15 min，即得。室温保存，有效期3天。

译文: Aqueous phase (0.2% TFA aqueous solution): Measure 400 μL TFA and add to 200 mL sterilized injection water, mix well, sonicate to remove bubbles for 15 min, then obtain. Store at room temperature, valid for 3 days.
------------------------------------------------------------------------------------
原文: 稀释液2（40 %乙腈水溶液）：量取200 mL 乙腈加至200 mL灭菌注射用水中，混匀即得。室温保存，有效期1个月。

译文: Aqueous solution 2 (40% Acetonitrile aqueous solution): Measure 200 mL Acetonitrile and add to 200 mL sterilized injection water, mix well to obtain. Store at room temperature, valid for 1 month.
------------------------------------------------------------------------------------
原文: 称取约10 mg clo（含量：99.75 %），以稀释液1溶解并定容至10 mL，配制成浓度约为1 mg/mL的质控储备液（浓度 = 称取量 × 纯度/体积）。命名为：配制日期-ST2-clo，例如：180101-ST2-clo。

译文: Accurately weigh 10 mg clo (content: 99.75%), dissolve in aqueous solution 1 and dilute to volume up to 10 mL, preparing a stock solution of approximately 1 mg/mL concentration (concentration = weight × purity/volume). Named as: preparation date-ST2-clo, for example: 180101-ST2-clo.
------------------------------------------------------------------------------------
原文: 试验报告及相关资料

译文: assay report and related data
------------------------------------------------------------------------------------
原文: 专题编号：A2018030-FA01

译文: study number: A2018030-FA01
------------------------------------------------------------------------------------
原文: 选择质控样品QC_X和标准曲线STD3_X作为储备液对比样品。命名为：SSC_QC_X和SSC_STD3_X。

译文: selection Quality Control Sample QC_X and Standard Curve STD3_X as stock solution comparison sample. Named as: SSC_QC_X and SSC_STD3_X.
------------------------------------------------------------------------------------
原文: Purge Wash、Seal Wash：灭菌注射用水 : 甲醇 = 90 : 10。

译文: Purge Wash、Seal Wash: sterilized injection water : Methanol = 90 : 10.
------------------------------------------------------------------------------------
原文: （室温遮光）

译文: (room temperature with light protection)
------------------------------------------------------------------------------------
原文: [3] 孟祥, 李莹, 潘琦, 姜娟, 等. 供试品检测在GLP研究中的意义及规范化要求[J]. 毒理学杂志, 2011, 25(6): 471-473.

译文: [3] Meng Xiang, Li Lin, Pan Jin, Jiang Ting, et al. Test article testing in GLP research significance and standardization requirements [J]. Toxicology Journal, 2011, 25(6): 471-473.
------------------------------------------------------------------------------------
原文: 纯水仪

译文: pure water instrument
------------------------------------------------------------------------------------
原文:  基本信息

译文:  General Information
------------------------------------------------------------------------------------
原文: 姓名：何艳；

译文: Name: He Yan;
------------------------------------------------------------------------------------
原文: 1.9.	试验关键日期	7

译文: 1.9.	Assay key dates	7
------------------------------------------------------------------------------------
原文: 参考品

译文: reference material
------------------------------------------------------------------------------------
原文: 2.	试验材料与方法	8

译文: 2.	Study Materials and Methods	8
------------------------------------------------------------------------------------
原文: sbk002给药制剂室温遮光稳定性：将D1配制的sbk002组给药制剂室温遮光放置至少2h和4 h后，再从给药制剂的上、中、下层各取1份样，按给药制剂处理方法进行处理后，进样分析。命名为：STA(Pre_2h)_A_1 、 STA(Pre_2h)_A_3、STA(Pre_2h)_A_5、STA(Pre_4h)_A_1、STA(Pre_4h)_A_3和STA(Pre_4h)_A_5。

译文: sbk002 dose formulations room temperature light protection stability: Place D1-prepared sbk002 dose formulations at room temperature with light protection for at least 2h and 4h, then take samples from the upper, middle, and lower layers of the dose formulations, respectively, and perform sample analysis according to the dose formulations treatment method. Named as: STA(Pre_2h)_A_1, STA(Pre_2h)_A_3, STA(Pre_2h)_A_5, STA(Pre_4h)_A_1, STA(Pre_4h)_A_3, and STA(Pre_4h)_A_5.
------------------------------------------------------------------------------------
原文: 何艳                                                                         日期

译文: He Yan                                                                         Date
------------------------------------------------------------------------------------
原文: 2.3.	主要仪器	9

译文: 2.3.	Major Instruments	9
------------------------------------------------------------------------------------
原文: 专题负责人

译文: study director
------------------------------------------------------------------------------------
原文: sbk002组

译文: sbk002 group
------------------------------------------------------------------------------------
原文: 供试品2

译文: test article 2
------------------------------------------------------------------------------------
原文: 专题名称：sbk002及硫酸氢氯吡格雷原料药给药制剂分析方法学验证试验

译文: 专题名称：sbk002及硫酸氢氯吡格雷原料药给药制剂分析方法学验证试验
------------------------------------------------------------------------------------
原文: 试验记录的管理

译文: assay record management
------------------------------------------------------------------------------------
原文: 1.8.	质量保证	7

译文: 1.8.	Quality Assurance	7
------------------------------------------------------------------------------------
原文: 三氟乙酸/ TFA

译文: Trifluoroacetic acid / TFA
------------------------------------------------------------------------------------
原文: 2.4.	主要试剂	10

译文: 2.4.	Major Reagents	10
------------------------------------------------------------------------------------
原文: 标准曲线

译文: Standard Curve
------------------------------------------------------------------------------------
原文: 选择质控样品QC_X作为质量控制样品，均匀分布于分析批中重复测定。分别命名为：PCS_QC_X_n（n表示在该分析批中第n次测定）。

译文: Select quality control sample QC_X as the quality control sample, and distribute it evenly in the analytical run for repeated determination. Named separately as: PCS_QC_X_n (n represents the nth determination in the analytical run).
------------------------------------------------------------------------------------
原文: 标准曲线样品的配制

译文: Standard Curve sample preparation
------------------------------------------------------------------------------------
原文: 加热磁力搅拌器

译文: heating magnetic stirrer
------------------------------------------------------------------------------------
原文: 质量保证人员

译文: quality assurance personnel
------------------------------------------------------------------------------------
原文: 分析数据所用的统计方法；

译文: assessment of data statistical method used;
------------------------------------------------------------------------------------
原文: 质控样品配制

译文: Quality Control Sample preparation
------------------------------------------------------------------------------------
原文: 1.	基本信息	6

译文: 1.	General Information	6
------------------------------------------------------------------------------------
原文: sbk002及硫酸氢氯吡格雷原料药

译文: sbk002 and 硼酸二氟烯甲骨原料药
------------------------------------------------------------------------------------
原文: 本机构代号：W2018027；

译文: Facility code: W2018027;
------------------------------------------------------------------------------------
原文: 电话：0512-36801688；

译文: Telephone: 0512-36801688;
------------------------------------------------------------------------------------
原文: 以稀释液2配制质控样品。

译文: Prepare quality control samples with diluent 2.
------------------------------------------------------------------------------------
原文: 注：给药制剂设计浓度为例值，以最终配制时实际浓度为准；稀释时，吸取量应适当调整，以确保设计浓度准确。

译文: Note: The designed concentration of the dose formulations is a reference value, with the actual concentration at the final preparation as the standard; during dilution, the aspirating volume should be appropriately adjusted to ensure the accuracy of the designed concentration.
------------------------------------------------------------------------------------
原文: sbk002质控样品配制

译文: sbk002 Quality Control Sample preparation
------------------------------------------------------------------------------------
原文: 5.	试验方案及变更、偏离	21

译文: 5.	Study Protocol and Amendments, Deviations	21
------------------------------------------------------------------------------------
原文: 超高效液相色谱仪的使用与维护

译文: Use and Maintenance of High-Performance Liquid Chromatography
------------------------------------------------------------------------------------
原文: 超声波清洗机

译文: Ultrasonic Cleaner
------------------------------------------------------------------------------------
原文: 电子邮件：cti-btc-qa.list@cti-cert.com。

译文: Email: cti-btc-qa.list@cti-cert.com。
------------------------------------------------------------------------------------
原文: 羧甲基纤维素钠/CMC-Na

译文: Carboxymethyl cellulose sodium / CMC-Na
------------------------------------------------------------------------------------
原文: 配制日期-WS2-clo

译文: preparation date-WS2-clo
------------------------------------------------------------------------------------
原文: Wash：灭菌注射用水 : 甲醇 = 10 : 90；

译文: Wash: sterilized injection water : Methanol = 10 : 90;
------------------------------------------------------------------------------------
原文: 注：QCL平行配制3份。

译文: Note: QCL parallel preparation 3 copies.
------------------------------------------------------------------------------------
原文: 影响研究可靠性和造成研究工作偏离试验方案的异常情况；

译文: affect research reliability and cause deviation in research work study protocol abnormalities;
------------------------------------------------------------------------------------
原文: 联系人：夏玉叶；

译文: Contact: Xia Yuye;
------------------------------------------------------------------------------------
原文: [5] 苏敏, 王京昆. 影响药物非临床安全性评价的供试品相关问题[J]. 中国药事, 2015, 29(2): 141-146.

译文: [5] Su Min, Wang Jingkun. Issues related to the test article affecting the non-clinical safety evaluation of drugs[J]. Chinese Pharmaceutical Affairs, 2015, 29(2): 141-146.
------------------------------------------------------------------------------------
原文: 地址：江苏省昆山市高新区元丰路166号；

译文: Address: 166 Yuanfeng Road, New & Hi-tech Industrial Development Zone, Kunshan City, Jiangsu Province;
------------------------------------------------------------------------------------
原文: 批号

译文: batch number
------------------------------------------------------------------------------------
原文: 1.7.	遵循的法规及技术指导原则	7

译文: 1.7.	Regulations and Technical Guiding Principles Followed	7
------------------------------------------------------------------------------------
原文: 原始资料的保存地点。

译文: Storage Location of Raw Materials.
------------------------------------------------------------------------------------
原文: clo标准曲线样品配制

译文: Clo Standard Curve Sample Preparation
------------------------------------------------------------------------------------
原文: 参考品和供试品等的名称/缩写名/代号、批号、含量/浓度等特性；

译文: Name/Abbreviated Name/Code, Batch Number, Content/Concentration, and other characteristics of Reference Material and Test Article;
------------------------------------------------------------------------------------
原文: 试剂级别

译文: Reagent Grade
------------------------------------------------------------------------------------
原文: Purge Wash、  Seal Wash（10 % 甲醇水溶液）：量取450 mL灭菌注射用水加至50 mL甲醇中，超声脱气泡15 min，即得。室温保存，有效期7天。

译文: Purge Wash、  Seal Wash（10 % 甲醇水溶液）：量取450 mL灭菌注射用水加至50 mL甲醇中，超声脱气泡15 min，即得。室温保存，有效期7天。
------------------------------------------------------------------------------------
原文: 6.	总结报告	21

译文: 6.	Final Report	21
------------------------------------------------------------------------------------
原文: 超高效液相色谱仪：ACQUITY UPLC H-Class，Waters；

译文: Ultra High Performance Liquid Chromatography: ACQUITY UPLC H-Class, Waters;
------------------------------------------------------------------------------------
原文: 1.5.	试验人员组成	6

译文: 1.5.	Composition of Study Personnel	6
------------------------------------------------------------------------------------
原文: （1）试验结束后2周内，专题负责人确保所有研究资料移交至档案室归档。

译文: (1) Within 2 weeks after the end of the assay, the study director ensures that all research data are transferred to the archives for filing.
------------------------------------------------------------------------------------
原文: 以上进样序列均可根据实际情况作适当调整，确保验证内容列表中的参数均被考察。

译文: The above injection sequences can be appropriately adjusted based on actual conditions to ensure that all parameters listed for validation are examined.
------------------------------------------------------------------------------------
原文: 7.	资料保存	22

译文: 7.	Storage of Relevant Data	22
------------------------------------------------------------------------------------
原文: 剩余样品处理：待检测合格后剩余给药制剂返还供试品管理部，按相关SOP要求进行处理。

译文: Remaining Sample Disposal: After testing qualification, return the remaining dose formulations to the test article management department and handle as per related SOP requirements.
------------------------------------------------------------------------------------
原文: 9.	主要参考文献	23

译文: 9.	Main References	23
------------------------------------------------------------------------------------
原文: 生产厂家：浙江车头制药股份有限公司；

译文: Manufacturer: Zhejiang Chemphead Pharmaceutical Co., Ltd.;
------------------------------------------------------------------------------------
原文: 版本

译文: Version
------------------------------------------------------------------------------------
原文: 联系人：武丽；

译文: Contact: Wu Li;
------------------------------------------------------------------------------------
原文: 保存场所与保存条件

译文: Storage Location and Storage Conditions
------------------------------------------------------------------------------------
原文: 对A2018030项目中测定供试品浓度的分析方法进行验证，并对给药制剂的配制方法及稳定性进行考察，确保供试品的质量和配制准确性，为临床前安全评价中发现的问题（如毒性与剂量关系等）提供可靠的科学参考。

译文: Validate the analytical method for determining test article concentration in project A2018030, examine the preparation method and stability of dose formulations to ensure the quality and accuracy of the test article, and provide reliable scientific reference for issues found in preclinical safety evaluations (such as toxicity and dose relationship).
------------------------------------------------------------------------------------
原文: 取样方法：取样前用磁力搅拌器以一定转速搅拌15 min及以上，转速设定以形成明显凹陷但不产生漩涡及大量气泡为准。从待测给药制剂的上、中、下层各取2份样，6份样均按下表进行处理。

译文: 取样方法：取样前用磁力搅拌器以一定转速搅拌15 min及以上，转速设定以形成明显凹陷但不产生漩涡及大量气泡为准。从待测给药制剂的上、中、下层各取2份样，6份样均按下表进行处理。
------------------------------------------------------------------------------------
原文: 空白溶剂样品在sbk002/clo保留时间处无干扰峰或干扰峰峰面积≤ 定量下限峰面积的10 %。

译文: Blank solvent samples have no interference peaks or interference peaks with peak area ≤ 10% of the lower limit of quantification peak area at the retention time of sbk002/clo.
------------------------------------------------------------------------------------
原文: 姓名：李萍；

译文: Name: Li Ping;
------------------------------------------------------------------------------------
原文: 试验方案

译文: Study Protocol
------------------------------------------------------------------------------------
原文: 专题负责人任命书

译文: Study Director Appointment Letter
------------------------------------------------------------------------------------
原文: 验证参数

译文: Validation Parameters
------------------------------------------------------------------------------------
原文: 阿拉丁/Aladdin

译文: Aladdin/Aladdin
------------------------------------------------------------------------------------
原文: 接受标准

译文: Acceptance Criteria
------------------------------------------------------------------------------------
原文: 四川科伦药业股份有限公司

译文: Sichuan Kelun Pharmaceutical Co., Ltd.
------------------------------------------------------------------------------------
原文: 吸取溶液

译文: Aspirating Solution
------------------------------------------------------------------------------------
原文: 试验方案及变更、偏离

译文: Study Protocol and Amendments, Deviations
------------------------------------------------------------------------------------
原文: 防护措施：按照《职业卫生安全与防护手册》操作，穿戴合适的个人防护设备（PPE）；

译文: Protection measures: operate according to the 'Occupational Health Safety and Protection Manual', wear appropriate personal protective equipment (PPE);
------------------------------------------------------------------------------------
原文: 注：“X”代表“sbk或clo”。

译文: Note: 'X' represents 'sbk or clo'.
------------------------------------------------------------------------------------
原文: 吸取上述储备液（配制日期-ST2-clo）约1 mL，用稀释液2定容至10 mL，得浓度为100 μg/mL的质控工作溶液，命名为：配制日期-WS2-clo，例如：180101-WS2-clo。

译文: Aspirate about 1 mL of the above stock solution (preparation date-ST2-clo), dilute to volume to 10 mL with diluent2, obtaining a quality control working solution with a concentration of 100 μg/mL and named as: preparation date-WS2-clo, e.g., 180101-WS2-clo.
------------------------------------------------------------------------------------
原文: 乙腈

译文: Acetonitrile
------------------------------------------------------------------------------------
原文: 设施内的所有原始数据根据试验方案和苏州华测生物技术有限公司的SOPs手动收集或用数据采集系统收集。手动收集的数据可以转录到Excel表格中用来分析和报告。收集和报告电子数据的采集系统如下：

译文: All raw data within the facility is collected manually or using data acquisition systems according to the study protocol and SOPs of Suzhou Huace Biotechnology Co., Ltd. Manually collected data can be transcribed into Excel tables for analysis and reporting. The data acquisition system for collecting and reporting electronic data is as follows:
------------------------------------------------------------------------------------
原文: 各试剂COA复印件/扫描件

译文: Copies/scanned copies of each reagent's COA
------------------------------------------------------------------------------------
原文: 试验原始资料（包括电子资料）

译文: Assay raw materials (including electronic data)
------------------------------------------------------------------------------------
原文: 纯度：99.75 %；

译文: Purity: 99.75 %；
------------------------------------------------------------------------------------
原文: 7.1.	归档时间及档案保存时间	22

译文: 7.1.	Archiving Time and Archives Storage Time	22
------------------------------------------------------------------------------------
原文: 8.	主要研究相关的SOP	23

译文: 8.	Main Study-Related SOP	23
------------------------------------------------------------------------------------
原文: 设计浓度（μg/mL）

译文: Design concentration (μg/mL)
------------------------------------------------------------------------------------
原文: 专题名称、编号及试验目的；

译文: Study Name, Number, and Objective;
------------------------------------------------------------------------------------
原文: Confidential                                                                           第 22页 /共 23页

译文: Confidential                                                                           Page 22 of 23
------------------------------------------------------------------------------------
原文: 选择质控样品QC_X作为系统适应性样品，于分析批前连续重复测定n次（n ≥ 6）来考察系统适应性，以最后6次的数值进行统计分析。命名为：SST_QC_X。

译文: Select Quality Control Sample QC_X as System Suitability Sample, perform repeated determination n times (n ≥ 6) before the analytical run to examine system suitability, and use the values of the last 6 determinations for statistical analysis. Named: SST_QC_X.
------------------------------------------------------------------------------------
原文: 剩余供试品处理：退回委托方。

译文: Handling of remaining test article: Return to the sponsor.
------------------------------------------------------------------------------------
原文: 传真：0512-36802288；

译文: Fax: 0512-36802288;
------------------------------------------------------------------------------------
原文: 邮编：215300；

译文: Postal code: 215300;
------------------------------------------------------------------------------------
原文: 冷冻离心机

译文: Freezing centrifuge
------------------------------------------------------------------------------------
原文: 梅特勒-托利多

译文: Mettler-Toledo
------------------------------------------------------------------------------------
原文: 进样盘温度：OFF； 

译文: Injection tray temperature: OFF；
------------------------------------------------------------------------------------
原文: 地址：

译文: Address:
------------------------------------------------------------------------------------
原文: 流速：0.3 mL/min；

译文: Flow rate: 0.3 mL/min;
------------------------------------------------------------------------------------
原文: 给药制剂

译文: Dose formulations
------------------------------------------------------------------------------------
原文: 平行配制3份QCL_X作为定量下限样品。命名为：LOQ_QCL_X_1 ~ LOQ_QCL_X_3。

译文: Preparation of 3 parallel QCL_X samples as limit of quantification samples. Named: LOQ_QCL_X_1 ~ LOQ_QCL_X_3.
------------------------------------------------------------------------------------
原文: 溶媒（0.5 %CMC-Na）的配制

译文: Preparation of vehicle (0.5 %CMC-Na)
------------------------------------------------------------------------------------
原文: 与试验有关的各种书面文件或报告

译文: Various written documents or reports related to the assay
------------------------------------------------------------------------------------
原文: 超高效液相色谱仪

译文: Ultra High Performance Liquid Chromatograph
------------------------------------------------------------------------------------
原文: 电子邮件：xiayuye@cti-cert.com。

译文: Email: xiayuye@cti-cert.com.
------------------------------------------------------------------------------------
原文: 标准曲线线性范围：5.0 μg/mL ~ 15.0 μg/mL。以对应化合物的标准曲线设计浓度为横坐标，以对应化合物的峰面积为纵坐标，求得直线回归方程。命名为：LR_STD1_X ~ LR_STD5_X。

译文: Standard curve linear range: 5.0 μg/mL ~ 15.0 μg/mL. The design concentration of the corresponding compound for the standard curve is the horizontal axis, and the peak area of the corresponding compound is the vertical axis, obtaining the linear regression equation. Named: LR_STD1_X ~ LR_STD5_X.
------------------------------------------------------------------------------------
原文: USP级

译文: USP grade
------------------------------------------------------------------------------------
原文: 本试验的实施除方案特殊说明外，均遵循本机构标准操作规程（Standard Operating Procedures，SOPs）。

译文: The implementation of this assay, unless otherwise specified in the protocol, complies with the standard operating procedures of the institution (Standard Operating Procedures, SOPs).
------------------------------------------------------------------------------------
原文: 回归系数（R2） ≥ 0.99，标准曲线线性各浓度回读准确度均应在90 % ~ 110 % 之间。

译文: Regression coefficient (R2) ≥ 0.99, the back-calculated accuracy of each concentration in the standard curve linearity should be between 90% - 110%.
------------------------------------------------------------------------------------
原文: 有效期至：2019-11-30；

译文: Expiry date: 2019-11-30;
------------------------------------------------------------------------------------
原文:  第一步稀释（S1）

译文:  First dilution (S1)
------------------------------------------------------------------------------------
原文: 吸取上述储备液（配制日期-ST2-sbk）约1 mL，用稀释液2定容至10 mL，得浓度为100 μg/mL的质控工作溶液，命名为：配制日期-WS2-sbk，例如：180101-WS2-sbk。

译文: Aspirate the aforementioned stock solution (preparation date-ST2-sbk) approximately 1 mL, dilute to volume with diluent 2 to 10 mL, to obtain a quality control working solution with a concentration of 100 μg/mL, named as: preparation date-WS2-sbk, for example: 180101-WS2-sbk.
------------------------------------------------------------------------------------
原文: 名称：成都施贝康生物医药科技有限公司；

译文: Name: Chengdu Shibekang Biomedical Technology Co., Ltd.;
------------------------------------------------------------------------------------
原文: 峰面积的比值在95 % ~ 105 % 之间。

译文: The ratio of Peak Area is between 95% ~ 105%.
------------------------------------------------------------------------------------
原文: 其它溶液的配制

译文: Preparation of other solutions
------------------------------------------------------------------------------------
原文: 供试品管理：陈晓艳；

译文: Test article management: Chen Xiaoyan；
------------------------------------------------------------------------------------
原文: 2.1.	参考品	8

译文: 2.1.	Reference	8
------------------------------------------------------------------------------------
原文: 信噪比S/N ≥ 10，准确度均应在95 % ~ 105 %之间， RSD ≤ 5 %。

译文: Signal-to-noise ratio (S/N) ≥ 10, accuracy should be between 95 % ~ 105 %, RSD ≤ 5 %.
------------------------------------------------------------------------------------
原文: clo给药制剂室温遮光稳定性：将D1配制的clo组给药制剂室温遮光放置至少4 h后，再从给药制剂的上、中、下层各取1份样，按给药制剂处理方法进行处理后，进样分析。命名为：STA(Pre_4h)_B_1 、 STA(Pre_4h)_B_3和STA(Pre_4h)_B_5。

译文: clo dose formulations room temperature light-protected stability: Place the clo dose formulations prepared by D1 at room temperature in light-protected conditions for at least 4 h, then take 1 sample each from the top, middle, and bottom layers of the dose formulations. Process according to the dose formulations treatment method, then analyze by injection. Named as: STA(Pre_4h)_B_1, STA(Pre_4h)_B_3, and STA(Pre_4h)_B_5.
------------------------------------------------------------------------------------
原文: 综合试验结果撰写报告初稿，并交予QA进行审核，形成终稿后由专题负责人及QA签字后交付委托方。

译文: Draft a report combining the assay results, submit it to QA for review, and after finalization, signed by the study director and QA, deliver it to the sponsor.
------------------------------------------------------------------------------------
原文: 生产厂家：成都施贝康生物医药科技有限公司；

译文: Manufacturer: Chengdu Shibekang Biomedical Technology Co., Ltd.;
------------------------------------------------------------------------------------
原文: 各组准确度均应在85 % ~ 115 %之间，批内及批间精密度RSD ≤ 10 %。

译文: The accuracy of each group should be between 85% ~ 115%, and the intra-batch and inter-batch precision RSD should be ≤ 10%.
------------------------------------------------------------------------------------
原文: 供试品1

译文: Test article 1
------------------------------------------------------------------------------------
原文: 名称

译文: Name
------------------------------------------------------------------------------------
原文: 配制方法举例（以1000 mL举例）：准确称取5.0 g的CMC-Na粉末，用量筒量取1000 mL纯水转移至烧杯中，将CMC-Na粉末均匀分散在烧杯中，加入搅拌子，用磁力搅拌器搅拌至完全溶解，即得0.5 % CMC-Na溶液1000 mL。室温存放，7天内有效。

译文: Preparation method example (for 1000 mL): Accurately weigh 5.0 g of CMC-Na powder, measure 1000 mL of pure water with a graduated cylinder, transfer to a beaker, evenly disperse the CMC-Na powder in the beaker, add a stir bar, stir with a magnetic stirrer until completely dissolved, to obtain 0.5% CMC-Na solution 1000 mL. Store at room temperature, effective within 7 days.
------------------------------------------------------------------------------------
原文: 江苏省昆山市高新区元丰路166号

译文: 166 Yuanfeng Road, High-tech Zone, Kunshan City, Jiangsu Province
------------------------------------------------------------------------------------
原文: 注：若试验中用到其它试剂，相关信息 (试剂名称、生产厂家等) 需在原始记录及总结报告中如实体现，以总结报告为准；纯水为苏州华测生物有限公司自制，批号为接取当日日期后六位。

译文: 注：若试验中用到其它试剂，相关信息 (试剂名称、生产厂家等) 需在原始记录及总结报告中如实体现，以总结报告为准；纯水为苏州华测生物有限公司自制，批号为接取当日日期后六位。
------------------------------------------------------------------------------------
原文: 3.1.	方法学验证内容列表	15

译文: 3.1.	Methodology validation content list	15
------------------------------------------------------------------------------------
原文: 质量保证部门遵照《药物非临床研究质量管理规范》（2017年09月），美国食品药品监督管理局（FDA）（21 CFR Part 58，Good Laboratory Practice For Nonclinical Laboratory Studies），经济合作与发展组织OECD [OECD Principles of Good Laboratory Practice, ENV/MC/CHEM (98)17]的GLP法规及本机构SOP对试验方案、方案变更、试验过程、原始数据和总结报告进行严格的监督、调查与审阅，以保证试验过程与试验结果的可信性。

译文: The quality assurance department complies with the 'Good Laboratory Practice for Non-Clinical Research of Pharmaceuticals' (September 2017), the U.S. Food and Drug Administration (FDA) (21 CFR Part 58, Good Laboratory Practice For Nonclinical Laboratory Studies), the OECD Principles of Good Laboratory Practice (ENV/MC/CHEM(98)17) of the Organization for Economic Cooperation and Development (OECD), and the SOP of the institution. It strictly supervises, investigates, and reviews the test plan, plan changes, testing process, original data, and summary reports to ensure the reliability of the testing process and results.
------------------------------------------------------------------------------------
原文: 2.5.	相关溶液等的配制	10

译文: 2.5.	related solution preparation	10
------------------------------------------------------------------------------------
原文: 供试品制剂分析

译文: test article formulation analyzed
------------------------------------------------------------------------------------
原文: 分析天平XSE105DU的使用和维护

译文: analyzed balance XSE105DU's use and maintenance
------------------------------------------------------------------------------------
原文: 流动相的配制

译文: mobile phase preparation
------------------------------------------------------------------------------------
原文: 称取约10 mg sbk002-D（含量：99.6 %），以稀释液1溶解并定容至10 mL，配制成浓度约为1 mg/mL的标曲储备液（浓度 = 称取量 × 含量/体积）。命名为：配制日期-ST1-sbk，例如：180101-ST1-sbk。

译文: Accurately weigh approximately 10 mg sbk002-D (content: 99.6%), dissolve in diluent 1 and dilute to a volume of 10 mL, to prepare a standard curve stock solution with a concentration of about 1 mg/mL (concentration = amount weighed × content/volume). Name it as: preparation date-ST1-sbk, for example: 180101-ST1-sbk.
------------------------------------------------------------------------------------
原文: 4.	数据采集和分析	21

译文: 4.	data acquisition and analysis	21
------------------------------------------------------------------------------------
原文: 预计试验开始日期：2018-12-04；

译文: Estimated assay start date: 2018-12-04;
------------------------------------------------------------------------------------
原文: 第二步稀释（S2）

译文: second dilution (S2)
------------------------------------------------------------------------------------
原文: 质量控制

译文: quality control
------------------------------------------------------------------------------------
原文: 研究机构

译文: test facility
------------------------------------------------------------------------------------
原文: 参数

译文: parameter
------------------------------------------------------------------------------------
原文: 电话：

译文: Telephone:
------------------------------------------------------------------------------------
原文: 各组稳定性样品的检测浓度与标示浓度比值在85 % ~ 115 % 之间，检测浓度与初始浓度比值在90 % ~ 110 %之间，稳定性样品RSD ≤ 10 %。

译文: Each group's stability sample testing concentration to labeled concentration ratio is between 85% ~ 115%, testing concentration to initial concentration ratio is between 90% ~ 110%, stability sample RSD ≤ 10%.
------------------------------------------------------------------------------------
原文: 吸取量      （μL）

译文: aspirating volume      （μL）
------------------------------------------------------------------------------------
原文: [4] 李耀庭, 梁金强, 黄芝瑛. 药物安全性评价研究中供试品的检测与分析[J]. 药物评价研究, 2014, 37(6): 541-543.

译文: [4] Li Yaoting, Liang Jinqiang, Huang Zhibo. Testing and analysis of test samples in the safety evaluation of drugs [J]. Drug Evaluation Research, 2014, 37(6): 541-543.
------------------------------------------------------------------------------------
原文: 配制日期-WS1-sbk

译文: preparation date-WS1-sbk
------------------------------------------------------------------------------------
原文: 含量：99.6 %；

译文: content: 99.6 %；
------------------------------------------------------------------------------------
原文: 运行定量上限样品（STD5_X）后，运行1个空白溶剂样品（稀释液2）。命名为：Carryover_X。

译文: After running the quantitative upper limit sample (STD5_X), run 1 blank solvent sample (Diluent 2). Named as: Carryover_X.
------------------------------------------------------------------------------------
原文: 配制方法：根据给药制剂浓度和配制体积等计算所需供试品量（sbk002给药制剂浓度 = 称取量 × 含量/体积；clo给药制剂浓度 = 称取量 × 纯度/体积）。在室温避光环境下，准确称取一定量的供试品至研钵中，加适量0.5 % CMC-Na溶液充分研磨后，完全转移至标定体积的容器中，用0.5 % CMC-Na定至刻度，即得所需浓度的给药制剂。

译文: Preparation method: Calculate the required test article amount based on dose formulation concentration and prepared volume (sbk002 dose formulation concentration = weight × content/volume; clo dose formulation concentration = weight × purity/volume). Under room temperature protected from excessive light, accurately weigh a certain amount of test article into a mortar, add an appropriate amount of 0.5% CMC-Na solution and grind thoroughly, then completely transfer into a container of calibrated volume, use 0.5% CMC-Na to volume, to obtain the required concentration of dose formulation.
------------------------------------------------------------------------------------
原文: 规格：51.8 g/袋；

译文: size: 51.8 g/bag；
------------------------------------------------------------------------------------
原文: 宁波新芝生物科技股份有限公司

译文: Ningbo Xinzhi Biotechnology Co., Ltd.
------------------------------------------------------------------------------------
原文: 1.3.	研究机构	6

译文: 1.3.	test facility	6
------------------------------------------------------------------------------------
原文: clo质控样品配制

译文: clo Quality Control Sample preparation
------------------------------------------------------------------------------------
原文: 运行时间：3 min（sbk002运行时间）；1.5 min（clo运行时间）

译文: run time: 3 min（sbk002 run time）；1.5 min（clo run time）
------------------------------------------------------------------------------------
原文: 检测波长：220 nm；

译文: testing wavelength: 220 nm；
------------------------------------------------------------------------------------
原文: 储备液对比

译文: Stock Solution Comparison
------------------------------------------------------------------------------------
原文: 成都高新区（西区）西芯大道17号

译文: Chengdu Hi-tech Zone (West Zone) Xixin Avenue No. 17
------------------------------------------------------------------------------------
原文: 注：若试验中用到其他批号供试品，相关信息需在原始记录及总结报告中如实记录及体现，以总结报告为准。

译文: Note: If other batch number test articles are used in the assay, relevant information should be truthfully recorded and reflected in the raw records and final report, based on the final report.
------------------------------------------------------------------------------------
原文: 试验方案的制订及变更

译文: Study protocol development and amendments
------------------------------------------------------------------------------------
原文: 专属性

译文: specificity
------------------------------------------------------------------------------------
原文: 以稀释液2配制标准曲线样品。

译文: Prepare standard curve samples with Diluent 2.
------------------------------------------------------------------------------------
原文: UPLC检测浓度

译文: UPLC testing concentration
------------------------------------------------------------------------------------
原文: 专属性样品的配制

译文: specificity sample preparation
------------------------------------------------------------------------------------
原文: 柱温：35 ℃；

译文: column temperature: 35 ℃；
------------------------------------------------------------------------------------
原文: 处理方法：按下表体积取待测给药制剂，第一步用稀释液1定容后，离心（10000 r/min，5 min，20 ℃），取上清液进行第二步稀释。第二步和第三步用稀释液2定容后，上机分析。

译文: Treatment method: After measuring the volume of the sample to be tested and preparing dose formulations, in the first step use dilute to volume 1, centrifuge (10000 r/min, 5 min, 20 ℃), collect the supernatant and proceed to the second step of dilution. For the second and third steps, dilute to volume 2, and then analyze.
------------------------------------------------------------------------------------
原文: 方法学验证内容列表

译文: Methodology validation content list
------------------------------------------------------------------------------------
原文: 目    录	4

译文: Table of Contents	4
------------------------------------------------------------------------------------
原文: 空白溶剂和空白溶媒样品在sbk002/clo保留时间处均无干扰峰或干扰峰峰面积 ≤ 定量下限峰面积的10 %。

译文: The retention time for blank diluent and blank vehicle samples in sbk002/clo showed no interference peaks or interfering peak area ≤ 10% of the lower limit of quantification.
------------------------------------------------------------------------------------
原文: 给药制剂处理后稳定性

译文: Stability after dose formulations treatment
------------------------------------------------------------------------------------
原文: 给药制剂稳定性

译文: Stability of dose formulations
------------------------------------------------------------------------------------
原文: 《药品注册管理办法》（原CFDA， 2007年10月）；

译文: 《Pharmaceuticals Registration Management Method》 (original CFDA, October 2007);
------------------------------------------------------------------------------------
原文: 其它资料

译文: Other materials
------------------------------------------------------------------------------------
原文: 针数

译文: Needle count
------------------------------------------------------------------------------------
原文: 遵循的法规及技术指导原则

译文: Compliant regulations and technical guidelines
------------------------------------------------------------------------------------
原文: 以溶媒（0.5 % CMC-Na）配制空白溶媒专属性样品：吸取400 μL 溶媒，用稀释液1定容至10 mL，离心（10000 r/min，5 min，20 ℃），吸取上清液20 μL，用稀释液2定容至20 mL，即得空白溶媒专属性样品，命名为：Select_V。

译文: Using vehicle (0.5% CMC-Na) to prepare a blank vehicle specific sample: aspirate 400 μL vehicle, dilute to volume 1 up to 10 mL, centrifuge (10000 r/min, 5 min, 20 ℃), aspirate 20 μL of the supernatant, dilute to volume 2 up to 20 mL to obtain the blank vehicle specific sample, named: Select_V.
------------------------------------------------------------------------------------
原文: 资料保存

译文: Storage of relevant data
------------------------------------------------------------------------------------
原文: 电子邮件：779061281@qq.com。

译文: Email: 779061281@qq.com.
------------------------------------------------------------------------------------
原文: 标识方法：sbk002组和clo组给药制剂分别用绿色和蓝色标签标识，注明专题编号、名称、浓度、数量、配制日期、配制者和成品编号；

译文: Identification method: For sbk002 and clo dose formulations, use green and blue labels respectively for characterization, indicate study number, name, concentration, quantity, preparation date, preparer, and finished product number;
------------------------------------------------------------------------------------
原文: 设计体积（mL）

译文: Design volume (mL)
------------------------------------------------------------------------------------
原文: 试验操作：王晓彤、陆明敏、丁伟芳、赵倩；

译文: Assay operators: XiaoFeng Wang, MingMin Lu, WeiFang Ding, YanZhao;
------------------------------------------------------------------------------------
原文: 归档时间及档案保存时间

译文: Archiving time and archive storage time
------------------------------------------------------------------------------------
原文: 批号：180704；

译文: Batch number: 180704;
------------------------------------------------------------------------------------
原文: 主要试剂

译文: Major reagents
------------------------------------------------------------------------------------
原文: [2] 顾利强, 辛艳飞, 高海燕,李峰, 等. GLP机构供试品分析相关问题的探讨[J]. 毒理学杂志, 2012, 26(5): 388-390.

译文: [2] LiQiang Gu, YanFei Xin, HaiYan Gao, Feng Li, et al. Discussion on issues related to GLP institution test article analysis [J]. Journal of Toxicology, 2012, 26(5): 388-390.
------------------------------------------------------------------------------------
原文: 第三步稀释（S3）

译文: Third step dilution (S3)
------------------------------------------------------------------------------------
原文: 溶液名称

译文: Solution name
------------------------------------------------------------------------------------
原文: 进样体积：1 μL；

译文: Sample volume: 1 μL;
------------------------------------------------------------------------------------
原文: 研究起止日期、试验起止日期；

译文: Research start and end dates, assay start and end dates;
------------------------------------------------------------------------------------
原文: 试剂名称

译文: Reagent name
------------------------------------------------------------------------------------
原文: 注：若试验中用到其它仪器设备，相关信息（名称、生产厂家等）会在原始记录及总结报告中如实体现，以总结报告为准。

译文: Note: If other apparatus is used in the assay, relevant information (name, manufacturer, etc.) will be recorded in the raw records and final report, with the final report being authoritative.
------------------------------------------------------------------------------------
原文: 目    录

译文: Table of Contents
------------------------------------------------------------------------------------
原文: 配制方法举例：

译文: Preparation method example:
------------------------------------------------------------------------------------
原文: 本人已确认该研究方案内容并同意实施。

译文: I have confirmed the research plan content and agree to its implementation.
------------------------------------------------------------------------------------
原文: 规格：2 g/袋；

译文: Specification: 2 g/bag;
------------------------------------------------------------------------------------
原文: 联系电话：0512-36801688。

译文: Contact telephone: 0512-36801688.
------------------------------------------------------------------------------------
原文: 委托方负责人（或代表）

译文: Sponsor responsible person (or representative)
------------------------------------------------------------------------------------
原文: 以稀释液2作为空白溶剂样品，命名为：Select_S；以溶媒配制空白溶媒专属性样品，命名为：Select_V；以AP_A_1和AP_B_1作为供试品专属性样品，分别命名为：Select_sbk和Select_clo。

译文: Using dilute to volume 2 as blank vehicle sample, named: Select_S; using vehicle preparation to prepare blank vehicle specific sample, named: Select_V; using AP_A_1 and AP_B_1 as test article specific samples, named: Select_sbk and Select_clo respectively.
------------------------------------------------------------------------------------
原文: 试验关键日期

译文: Assay key dates
------------------------------------------------------------------------------------
原文: 用途

译文: Purpose
------------------------------------------------------------------------------------
原文: 提供单位：成都施贝康生物医药科技有限公司；

译文: Supplier: Chengdu Sbark Biotechnology Co., Ltd.;
------------------------------------------------------------------------------------
原文: 包括但不限于以下内容：

译文: Including but not limited to the following contents:
------------------------------------------------------------------------------------
原文: clo组

译文: clo group
------------------------------------------------------------------------------------
原文: 报告拟记载的主要内容

译文: Main contents simulated in the report
------------------------------------------------------------------------------------
原文: 注：实际测定时，样品名之前增加进样日期以示区别，例如：180101_SST_QC_sbk。

译文: Note: During actual determination, the sample name should be prefixed with the Date of Injection for distinction, e.g., 180101_SST_QC_sbk.
------------------------------------------------------------------------------------
原文: （3）以上各申报条件下的研究所产生的湿标本及其它生物标本均以不影响其评价质量的保存时间为限，如该时限超出第（2）项中的时限，则以第（2）项中时限为准。

译文: (3) The storage time limits for the wet specimens and other biological specimens produced under the above application conditions should not affect their evaluation quality. If the time limit exceeded the limit specified in item (2), then the time limit in item (2) shall prevail.
------------------------------------------------------------------------------------
原文: 2.2.	供试品	8

译文: 2.2.	Test article	8
------------------------------------------------------------------------------------
原文: 灭菌注射用水

译文: Sterilized injection water
------------------------------------------------------------------------------------
原文: sbk002标准曲线样品的配制

译文: Preparation of sbk002 standard curve samples
------------------------------------------------------------------------------------
原文: 试验方案及方案变更（如有）

译文: Study protocol and protocol amendments (if any)
------------------------------------------------------------------------------------
原文: 稳定性

译文: Stability
------------------------------------------------------------------------------------
原文:     D1进样序号

译文:     D1 sample sequence number
------------------------------------------------------------------------------------
原文:     D2进样序号

译文:     D2 sample sequence number
------------------------------------------------------------------------------------
原文: 批号：20171201；

译文: Batch number: 20171201;
------------------------------------------------------------------------------------
原文: 移液器的使用与维护

译文: Use and maintenance of liquid transfer devices
------------------------------------------------------------------------------------
原文: 吸取上述储备液（配制日期-ST1-sbk）约1 mL，用稀释液2定容至10 mL，得浓度为100 μg/mL的标曲工作溶液，命名为：配制日期-WS1-sbk，例如：180101-WS1-sbk。

译文: Aspirate the above-prepared stock solution (preparation date-ST1-sbk) about 1 mL and dilute it to 10 mL with 2D deionized water, obtaining a standard working solution with a concentration of 100 μg/mL named as (preparation date-WS1-sbk), for example: 180101-WS1-sbk.
------------------------------------------------------------------------------------
原文: 给药制剂取样和处理方法

译文: Sampling and processing methods of dose formulations
------------------------------------------------------------------------------------
原文: 注：实际测定时，样品名之前增加进样日期以示区别，例如：180101_SST_QC_sbk；“*”标示处表示可以设定的一定的Delay时长，以确保稳定性考察样品的放置时间符合方案所述时长。

译文: Note: In actual determination, the sample name should be prefixed with the Date of Injection to indicate the distinction, e.g., 180101_SST_QC_sbk. The "*" mark indicates that a certain delay period can be set to ensure that the placement time of stability test samples meets the duration specified in the protocol.
------------------------------------------------------------------------------------
原文: 牟霞                                                                         日期

译文: Miao Cheng                                                                         Date
------------------------------------------------------------------------------------
原文: 准确称取12.5 g的clo至研钵中，用0.5 % CMC-Na溶液充分研磨后，完全转移至标定体积（50 mL）的容器中，用0.5 % CMC-Na定至刻度，即得250 mg/mL的clo组给药制剂。

译文: Accurately weigh 12.5 g of clo into the mortar, grind it thoroughly with 0.5% CMC-Na solution, and then transfer completely to a volumetric container of 50 mL. Adjust the volume to the mark with 0.5% CMC-Na solution, thus obtaining a clo dose formulation of 250 mg/mL.
------------------------------------------------------------------------------------
原文: 1.1.	专题名称及编号	6

译文: 1.1.	Study Name and Code	6
------------------------------------------------------------------------------------
原文: 主要参考文献

译文: Main reference literature
------------------------------------------------------------------------------------
原文: 专题名称：sbk002及硫酸氢氯吡格雷原料药给药制剂分析方法学验证试验；

译文: Study Name: sbk002 and zinc oxide glyphosate raw material dose formulations analytical methodology validation assay;
------------------------------------------------------------------------------------
原文: 运输条件：室温、遮光。

译文: Transport conditions: room temperature, light-shielded.
------------------------------------------------------------------------------------
原文: 设计浓度

译文: Design concentration
------------------------------------------------------------------------------------
原文: 试验人员组成

译文: Composition of study personnel
------------------------------------------------------------------------------------
原文: 组别

译文: Group
------------------------------------------------------------------------------------
原文: 相关溶液等的配制

译文: Preparation of related solutions, etc.
------------------------------------------------------------------------------------
原文: 规格：38 g/袋；

译文: Specification: 38 g/bag;
------------------------------------------------------------------------------------
原文: 离心机（Eppendorf）的使用与维护

译文: Use and maintenance of centrifuge (Eppendorf)
------------------------------------------------------------------------------------
原文: 名称：

译文: Name:
------------------------------------------------------------------------------------
原文: 含量：99.8 %；

译文: Purity: 99.8%;
------------------------------------------------------------------------------------
原文: 电子邮件：liping@cti-cert.com。

译文: Email: liping@cti-cert.com.
------------------------------------------------------------------------------------
原文: 名称/代号：硫酸氢氯吡格雷/clo；

译文: Name/Code: Zinc oxide glyphosate/clo;
------------------------------------------------------------------------------------
原文: 2.6.	分析方法	14

译文: 2.6.	Analyzed method	14
------------------------------------------------------------------------------------
原文: 等度洗脱，水相 : 有机相 = 55: 45；

译文: Isocratic elution, water phase: organic phase = 55:45;
------------------------------------------------------------------------------------
原文: 性状：白色结晶性粉末；

译文: Appearance: White crystalline powder;
------------------------------------------------------------------------------------
原文: 有效期至：2020-08-20（暂定）；

译文: Expiry date: 2020-08-20 (tentative);
------------------------------------------------------------------------------------
原文: 归档内容

译文: Archived data
------------------------------------------------------------------------------------
原文: 地址：成都高新区（西区）西芯大道17号；

译文: Address: Chengdu New & Hi-tech Industrial Development Zone (West Zone), Xixin Avenue No. 17;
------------------------------------------------------------------------------------
原文: 超标结果 (OOS )调查

译文: Out-of-specification result (OOS) investigation
------------------------------------------------------------------------------------
原文: 试验方案及方案的任何变更（如果有）将以书面的形式经专题负责人、质量保证部门人员签字生效；委托单位代表在签字页上签字或者发送邮件认可试验方案；方案变更（如有必要）需委托单位代表签字或发送邮件确认。偏离试验方案的情况均应记录，以书面的形式由专题负责人分析对专题研究可能产生的影响，必要时采取相应的纠错措施。

译文: The translation should be professional, complete, and must not omit any words. Study protocols and any amendments (if any) shall take effect upon being signed in writing by the Study Director and Quality Assurance Department personnel; Sponsor representatives shall either sign on the signature page or send an email to approve the study protocol; any protocol amendments (if necessary) shall be signed by the sponsor representative or confirmed via email. All deviations from the study protocol should be recorded, and the Study Director shall analyze them in writing to determine potential impacts on the study, taking corrective measures if necessary.
------------------------------------------------------------------------------------
原文: 试验材料与方法

译文: Study Materials and Methods
------------------------------------------------------------------------------------
原文: 分析天平

译文: Analyzed Average
------------------------------------------------------------------------------------
原文: 3.	方法学验证	15

译文: 3.	Methodology Validation	15
------------------------------------------------------------------------------------
原文: 生产厂家

译文: Manufacturer
------------------------------------------------------------------------------------
原文: 准确度与精密度

译文: Accuracy and Precision
------------------------------------------------------------------------------------
原文:     D3进样序号

译文:     D3 Sample Sequence Number
------------------------------------------------------------------------------------
原文: 线性范围

译文: Linear Range
------------------------------------------------------------------------------------
原文: 委托方签字页

译文: Sponsor Signature Page
------------------------------------------------------------------------------------
原文: 保存条件：15 ~ 25 ℃、密闭、遮光、干燥；

译文: Storage Condition: 15 ~ 25 ℃, airtight, light-proof, dry;
------------------------------------------------------------------------------------
原文: （2）本研究如用于注册申报，其档案保存期为药物上市后至少五年；本研究如不用于注册申报，其档案保存期为试验报告批准日后至少五年。

译文: （2）If this study is used for registration application, its archive storage period shall be at least 5 years after the medication is marketed; if this study is not for registration application, its archive storage period shall be at least 5 years after the assay report approval date.
------------------------------------------------------------------------------------
原文: 专题名称及编号

译文: Study Name and Number
------------------------------------------------------------------------------------
原文: 配制方法：准确称取一定量的CMC-Na粉末，用量筒量取一定体积的纯水转移至烧杯中，将CMC-Na粉末均匀分散在烧杯中，加入搅拌子，用磁力搅拌器搅拌至完全溶解，即得0.5%的CMC-Na溶液。

译文: Preparation method: Accurately weigh a certain amount of CMC-Na powder, use a measuring cylinder to measure a certain volume of pure water and transfer it to a beaker. Evenly disperse the CMC-Na powder in the beaker, add a stirring rod, and use a magnetic stirrer to stir until completely dissolved, obtaining a 0.5% CMC-Na solution.
------------------------------------------------------------------------------------
原文: 称取约10 mg sbk002-D（含量：99.6%），以稀释剂1溶解并定容至10 mL，配制成浓度约为1 mg/mL的质控储备液（浓度 = 称取量 × 含量/体积）。命名为：配制日期-ST2-sbk，例如：180101-ST2-sbk。

译文: Weigh approximately 10 mg sbk002-D (content: 99.6%), dissolve in diluent 1 and dilute to a final volume of 10 mL, to prepare a quality control stock solution with a concentration of approximately 1 mg/mL (concentration = weighed amount × content/volume). Named as: Preparation date-ST2-sbk, for example: 180101-ST2-sbk.
------------------------------------------------------------------------------------
原文: Wash（90% 甲醇水溶液）：量取450 mL甲醇加至50 mL灭菌注射用水中，超声脱气15 min，即得。室温保存，有效期1个月。

译文: Wash (90% Methanol aqueous solution): Measure 450 mL Methanol and add to 50 mL sterile water for injection, sonicate to degas for 15 min, to obtain the solution. Store at room temperature, valid for 1 month.
------------------------------------------------------------------------------------
原文: 给药制剂配制：刘露露、韩月、石磊磊；

译文: Dose formulations preparation: Liu Lulu, Han Yue, Shi Leilei;
------------------------------------------------------------------------------------
原文: 各溶液等可根据实际需要和相应配制比例调整配制体积。未注明有效期的溶液等（除给药制剂外）均为现配现用。将首次配制标准曲线样品的日期定义为第一天（Day1/D1），以此类推至第n天（Day n/Dn）。

译文: The preparation volume of each solution can be adjusted according to actual needs and corresponding preparation ratios. Solutions without a specified expiry date (except dose formulations) are prepared and used immediately. The date of the first preparation of standard curve samples is defined as the first day (Day1/D1), and so on until the nth day (Day n/Dn).
------------------------------------------------------------------------------------
原文: 稀释剂1（乙腈）：分取200 mL乙腈，即得。室温保存，有效期1个月。

译文: Diluent 1 (Acetonitrile): Measure 200 mL of acetonitrile, then obtain the solution. Store at room temperature, valid for 1 month.
------------------------------------------------------------------------------------
原文: 注：以上人员如有变动，具体信息在原始记录和总报告中如实体现。

译文: Note: If there are any changes in the above personnel, detailed information will be accurately reflected in the raw records and final report.
------------------------------------------------------------------------------------
原文: 专题名称： sbk002及硫酸氢氯吡格雷原料药给药制剂分析方法学验证试验

译文: Study Name: sbk002 and hydrofluoric acid osteology raw material dose formulation analytical methodology validation assay
------------------------------------------------------------------------------------
原文: 选择质控样品 QC_X 作为质量控制样品，均匀分布于分析批中重复测定。 分别命名为： PCS_QC_X_n（n表示在该分析批中第n次测定）。

译文: selecting Quality Control Sample QC_X as quality control sample, uniformly distributed in analytical run repeated determination. Respectively named: PCS_QC_X_n (n indicates the nth determination in the analytical run).
------------------------------------------------------------------------------------
原文: 以稀释液 2 配制质控样品。

译文: Prepare quality control samples using Diluent 2.
------------------------------------------------------------------------------------
原文: 注：给药制剂设计浓度为例值，以最终配制时实际浓度为准； 稀释时，吸取量应适当调整，以确保设计浓度准确。

译文: Note: dose formulations design concentration as a reference value, based on the actual concentration during the final preparation; during dilution, the aspirating volume should be appropriately adjusted to ensure the accuracy of the design concentration.
------------------------------------------------------------------------------------
原文: 电子邮件： cti-btc-qa.list@cti-cert.com 。

译文: Email: cti-btc-qa.list@cti-cert.com.
------------------------------------------------------------------------------------
原文: Purge Wash、 Seal Wash（10% 甲醇水溶液）：量取450 mL灭菌注射用水加入50 mL甲醇中，超声脱气溶液15 min，即得。室温保存，有效期7天。

译文: Purge Wash, Seal Wash (10% Methanol Aqueous Solution): Measure 450 mL of sterilized water for injection, add it to 50 mL of methanol, sonicate to degas the solution for 15 minutes, and it is ready. Store at room temperature, valid for 7 days.
------------------------------------------------------------------------------------
原文: 取样方法：取样前用磁力搅拌器以一定转速搅拌15 min及以上，转速设定以形成明显凹陷但不产生涡流及大量气泡为准。从待测给药制剂的上、中、下层各取2份样，6份样均按下表进行处理。

译文: Sampling method: Before sampling, stir with a magnetic stirrer at a certain speed for 15 minutes or more. The speed should be set to form a clear depression without generating vortices or a large number of bubbles. Take 2 samples from the upper, middle, and lower layers of the dose formulations to be tested, and process the 6 samples as per the table below.
------------------------------------------------------------------------------------
原文: 空白溶剂样品在sbk002/clo保留时间处无干扰峰或干扰峰峰面积≤ 定量下限峰面积的10%。

译文: Blank solvent sample shows no interference peaks at the retention time of sbk002/clo or the area of interfering peaks is ≤ 10% of the area of the lower limit of quantification peak.
------------------------------------------------------------------------------------
原文: 吸取上述储备液（配制日期-ST2-clo）约1 mL，用稀释液2定容至10 mL，得浓度为100 µg/mL的质控工作溶液，命名为：配制日期-WS2-clo，例如：180101-WS2-clo。

译文: Aspirate the above-mentioned stock solution (preparation date-ST2-clo) about 1 mL, dilute to volume with diluent 2 to 10 mL, to obtain a quality control working solution with a concentration of 100 µg/mL, named: preparation date-WS2-clo, for example: 180101-WS2-clo.
------------------------------------------------------------------------------------
原文: 纯度：99.75%；

译文: Purity: 99.75%;
------------------------------------------------------------------------------------
原文: 设计浓度（µg/mL）

译文: Design concentration (µg/mL)
------------------------------------------------------------------------------------
原文: 进样盘温度：OFF；

译文: Sample plate temperature: OFF;
------------------------------------------------------------------------------------
原文: 标准曲线线性范围：5.0 µg/mL ~ 15.0 µg/mL。以对应化合物的标准曲线设计浓度为横坐标，以对应化合物的峰面积为纵坐标，求得直线回归方程。命名为：LR_STD1_X ~ LR_STD5_X。

译文: Standard Curve linear range: 5.0 µg/mL ~ 15.0 µg/mL. The design concentration of the corresponding compound's standard curve is the x-axis, and the peak area of the corresponding compound is the y-axis, to derive the linear regression equation. Named: LR_STD1_X ~ LR_STD5_X.
------------------------------------------------------------------------------------
原文: 本试验的实施除方案特殊说明外，均遵循本机构标准操作规程（Standard Operating Procedures, SOPs）。

译文: The implementation of this assay, except for the specific instructions in the protocol, complies with the standard operating procedures of the testing facility (Standard Operating Procedures, SOPs).
------------------------------------------------------------------------------------
原文: 回归系数（R2） ≥ 0.99，标准曲线线性各浓度回读准确度均应在90 % ~ 110 %之间。

译文: Regression coefficient (R2) ≥ 0.99, the back-calculated accuracy of each concentration of the standard curve linearity should be between 90 % ~ 110 %.
------------------------------------------------------------------------------------
原文:  第一 步稀释（S1）

译文:  Step 1 dilution (S1)
------------------------------------------------------------------------------------
原文: 供应商管理：陈晓艳；

译文: Vendor management: Chen Xiaoyan;
------------------------------------------------------------------------------------
原文: 2.1. 参考品 8

译文: 2.1. Reference article 8
------------------------------------------------------------------------------------
原文: 信噪比S/N ≥ 10，准确度均应在95 % ~ 105 %之间，RSD ≤ 5 %。

译文: Signal-to-noise ratio S/N ≥ 10, accuracy should be between 95% ~ 105%, RSD ≤ 5%.
------------------------------------------------------------------------------------
原文: Clo给药制剂室温遮光稳定性：将D1配制的Clo组给药制剂室温遮光放置至少4h后，再从给药制剂的上、中、下层各取1份样，按给药制剂处理方法进行处理后，进样分析。命名为：STA(Pre_4h)_B_1 、STA(Pre_4h)_B_3和STA(Pre_4h)_B_5。

译文: Clo dose formulations room temperature light-shielded stability: Place the D1-prepared Clo dose formulations at room temperature light-shielded for at least 4 hours, then take 1 sample each from the top, middle, and bottom layers of the dose formulation, process according to the dose formulation treatment method, and analyze the samples. Named as: STA(Pre_4h)_B_1, STA(Pre_4h)_B_3, and STA(Pre_4h)_B_5.
------------------------------------------------------------------------------------
原文: 综合实验结果撰写报告初稿，并交予QA进行审核，形成终稿后由专题负责人及QA签字后交付委托方。

译文: Write a draft report of the comprehensive experimental results, submit it to QA for review, form the final version, and after being signed by the study director and QA, deliver it to the sponsor.
------------------------------------------------------------------------------------
原文: 注：若实验中用到其它试剂，相关信息 (试剂名称、生产厂家等) 需在原始记录及总结报告中如实体现，以总结报告为准；纯水为苏州华测生物有限公司自制，批号为接取当日日期后六位。

译文: Note: If other reagents are used in the experiment, relevant information (reagent name, manufacturer, etc.) should be accurately reflected in the raw record and final report, with the final report prevailing; pure water is self-made by Suzhou Huace Bio-technology Co., Ltd., batch number is the last six digits of the date collected.
------------------------------------------------------------------------------------
原文: 3.1. 方法学验证内容列表 15

译文: 3.1. Methodology validation content listing 15
------------------------------------------------------------------------------------
原文: 质量保证部门遵照《药物非临床研究质量管理规范》（2017年09月）、美国食品药品监管局（FDA）（21 CFR Part 58，Good Laboratory Practice For Nonclinical Laboratory Studies）、经济合作与发展组织OECD [OECD Principles of Good Laboratory Practice, ENV/MC/CHEM(98)17]的GLP法规及本机构SOP对实验方案、方案变更、实验过程、原始数据和总结报告进行严格的监督、稽查与审阅，以保证实验过程与实验结果的可信性。

译文: The quality assurance department, in accordance with the 'Good Laboratory Practices for Nonclinical Laboratory Studies' (2017 September), the U.S. Food and Drug Administration (FDA) (21 CFR Part 58, Good Laboratory Practice For Nonclinical Laboratory Studies), the Organization for Economic Cooperation and Development OECD [OECD Principles of Good Laboratory Practice, ENV/MC/CHEM(98)17] GLP regulations and the organization's SOP, strictly supervises, audits and reviews the study protocol, protocol amendments, study process, raw data, and final report to ensure the credibility of the study process and results.
------------------------------------------------------------------------------------
原文: 称取约10 mg sbk002-D（含量：99.6 %），以稀释溶液1溶解并定容至10 mL，配制成浓度约为1 mg/mL的标准储备液（浓度 = 称取量 × 含量/体积）。命名为：配制日期-ST1-sbk，例如：180101-ST1-sbk。

译文: Weigh approximately 10 mg sbk002-D (content: 99.6%), dissolve in dilution solution 1 and dilute to volume up to 10 mL, prepare a standard stock solution with a concentration of approximately 1 mg/mL (concentration = weight × content/volume). Name as: preparation date-ST1-sbk, for example: 180101-ST1-sbk.
------------------------------------------------------------------------------------
原文: [4] 李耀廷, 梁金强, 黄芝玮. 药物安全性评价研究中供试品的检测与分析[J]. 药物评价研究, 2014, 37(6): 541-543.

译文: [4] Li Yao Ting, Liang Jin Qiang, Huang Zhi Wei. Testing and analysis of test articles in medication safety evaluation study [J]. Medication Evaluation Research, 2014, 37(6): 541-543.
------------------------------------------------------------------------------------
原文: 运行定量上限样品（STD5_X）后，运行1个空白溶剂样品（稀释溶液2）。命名为：Carryover_X。

译文: After running the upper limit sample (STD5_X), run 1 blank solvent sample (dilution solution 2). Named: Carryover_X.
------------------------------------------------------------------------------------
原文: 试验方案的制定及变更

译文: study protocol development and amendments
------------------------------------------------------------------------------------
原文: 以稀释溶液2配制标准曲线样品。

译文: Use dilution solution 2 to prepare standard curve sample.
------------------------------------------------------------------------------------
原文: 配制方法：准确称取一定量的CMC-Na粉末，用量筒量取一定体积的纯水转移至烧杯中，将CMC-Na粉末均匀分散在烧杯中，加入搅拌子，用磁力搅拌器搅拌至完全溶解，即得0.5% CMC-Na溶液。

译文: Preparation method: Accurately weigh a specific amount of CMC-Na powder, measure a certain volume of pure water with a measuring cylinder, transfer to a beaker, evenly disperse the CMC-Na powder in the beaker, add a stirring bar, and stir with a magnetic stirrer until completely dissolved to obtain a 0.5% CMC-Na solution.
------------------------------------------------------------------------------------
原文: 称取约10 mg sbk002-D（含量：99.6%），以稀释液1溶解并定容至10 mL，配制成浓度约为1 mg/mL的质控储备液（浓度 = 称取量 × 含量/体积）。命名为：配制日期-ST2-sbk，例如：180101-ST2-sbk。

译文: Weigh approximately 10 mg sbk002-D (content: 99.6%), dissolve in diluent 1 and dilute to volume to 10 mL, preparing a quality control stock solution with a concentration of approximately 1 mg/mL (concentration = weight × content/volume). Named as: preparation date-ST2-sbk, for example: 180101-ST2-sbk.
------------------------------------------------------------------------------------
原文: 联系人：苗霖；

译文: Contact person: Miao Lin;
------------------------------------------------------------------------------------
原文: 专题名称：sbk002及氢酸氧氯苯格雷原料药给药制剂分析方法学验证试验

译文: Study Name: sbk002 and hydrogen sulfate clopidogrel raw material drug dose formulations analytical methodology validation assay
------------------------------------------------------------------------------------
原文: sbk002及氢酸氧氯苯格雷原料药

译文: sbk002 and hydrogen sulfate clopidogrel raw material drug
------------------------------------------------------------------------------------
原文: Purge Wash、Seal Wash（10 % 甲醇水溶液）：量取450 mL灭菌注射用水加至50 mL甲醇中，超声脱气15 min，即得。室温保存，有效期7天。

译文: Purge Wash、Seal Wash (10 % Methanol aqueous solution)：Take 450 mL of sterilized water for injection and add it to 50 mL of Methanol, sonicate for 15 min to remove air bubbles. Store at room temperature, valid for 7 days.
------------------------------------------------------------------------------------
原文: 取样方法：取样前用磁力搅拌器以一定转速搅拌15 min及以上，转速设定以形成明显凹陷但不产生涡漩及大量气泡为准。从待测给药制剂的上、中、下层各取2份样，6份样均按下表进行处理。

译文: sampling method: Before sampling, use a magnetic stirrer to stir at a certain speed for 15 min or more, the speed setting should form a noticeable depression but not create vortices or a large number of bubbles. Take 2 samples from the top, middle, and bottom layers of the dose formulations to be tested, 6 samples in total, and process them according to the table below.
------------------------------------------------------------------------------------
原文: 注：若试验中用到其它试剂，相关信息 (试剂名称、生产厂家等) 需在原始记录及总结报告中如实体现，以总结报告为准；纯水为苏州华测生物有限公司自制，批号为接取当天日期后六位。

译文: Note: If other reagents are used in the test, relevant information (reagent name, manufacturer, etc.) should be accurately reflected in the original records and summary report, with the summary report taking precedence; pure water is self-made by Suzhou Huace Bio Co., Ltd., and the batch number is the last six digits of the date of collection.
------------------------------------------------------------------------------------
原文: 称取约10 mg sbk002-D（含量：99.6%），以稀释液1溶解并定容至10 mL，配制成浓度约为1 mg/mL的标准储备液（浓度 = 称取量 × 含量/体积）。命名为：配制日期-ST1-sbk，例如：180101-ST1-sbk。

译文: Weigh approximately 10 mg of sbk002-D (content: 99.6%), dissolve with Diluent 1 and dilute to volume up to 10 mL to prepare a standard stock solution with a concentration of approximately 1 mg/mL (concentration = weight × content/volume). Named as: preparation date-ST1-sbk, for example, 180101-ST1-sbk.
------------------------------------------------------------------------------------
原文: [4] 李耀庭, 梁金强, 黄芝琼. 药物安全性评价研究中供试品的检测与分析[J]. 药物评价研究, 2014, 37(6): 541-543.

译文: [4] Li Yaoting, Liang Jinqiang, Huang Zhiqiong. Detection and Analysis of Test Articles in Drug Safety Evaluation Research [J]. Drug Evaluation Research, 2014, 37(6): 541-543.
------------------------------------------------------------------------------------
原文: 实验方案的制定及变更

译文: The formulation and amendments of the study protocol
------------------------------------------------------------------------------------
原文: 专题名称： sbk002及磷酸二氢钾原料药给药制剂分析方法学验证试验

译文: Study Name: Methodology Validation Assay for sbk002 and Monopotassium Phosphate Raw Material Dose Formulations
------------------------------------------------------------------------------------
原文: Wash（90 % 甲醇水溶液）：量取450 mL甲醇加至50 mL灭菌注射用水中，超声脱气15 min，即得。室温保存，有效期1个月。

译文: Wash (90% Methanol aqueous solution): Measure 450 mL of Methanol and add it to 50 mL of sterilized injection water, sonicate to degas for 15 min, and it is ready. Store at room temperature, valid for 1 month.
------------------------------------------------------------------------------------
原文: 联系人：毛霭；

译文: Contact person: Mao Ai;
------------------------------------------------------------------------------------
原文: 专题名称：sbk002及硫酸乙酰苯胺格雷原料药给药制剂分析方法学验证试验

译文: Study Name: sbk002 and Sulfasalazine Acetanilide Grey API Dose Formulations Analysis Methodology Validation Test
------------------------------------------------------------------------------------
原文: sbk002及硫酸乙酰苯胺格雷原料药

译文: sbk002 and Sulfasalazine Acetanilide Grey API
------------------------------------------------------------------------------------
原文: Purge Wash、 Seal Wash（10 % 甲醇水溶液）：量取450 mL灭菌注射用水加至50 mL甲醇中，超声脱气15 min，即得。室温保存，有效期7天。

译文: Purge Wash, Seal Wash (10% Methanol aqueous solution): Measure 450 mL sterilized injection water and add it to 50 mL Methanol, sonicate to degas for 15 min, and it is ready. Store at room temperature, valid for 7 days.
------------------------------------------------------------------------------------
原文: Wash（90 % 甲醇水溶液）：量取450 mL甲醇加入50 mL灭菌注射用水中，超声脱气搅拌15 min，即得。室温保存，有效期1个月。

译文: Wash（90 % Methanol solution）：Measure 450 mL of methanol and add it to 50 mL of sterilized water for injection, sonicate to de-gas for 15 min, and obtain. Store at room temperature, valid for 1 month.
------------------------------------------------------------------------------------
原文: 联系人：牟霆；

译文: Contact person: Mou Ting;
------------------------------------------------------------------------------------
原文: 专题名称：sbk002及磷酸氢钙柠檬酸盐原料药给药制剂分析方法学验证试验

译文: Study Name：sbk002 and Dibasic Calcium Phosphate Crospovidone Excipient Dose Formulation Analytical Method Validation Assay
------------------------------------------------------------------------------------
原文: sbk002及磷酸氢钙柠檬酸盐原料药

译文: sbk002 and Dibasic Calcium Phosphate Crospovidone Excipient
------------------------------------------------------------------------------------
原文: Purge Wash、 Seal Wash（10 % 甲醇水溶液）：量取450 mL灭菌注射用水加入50 mL甲醇中，超声脱气搅拌15 min，即得。室温保存，有效期7天。

译文: Purge Wash、 Seal Wash（10 % Methanol solution）：Measure 450 mL of sterilized water for injection and add it to 50 mL of methanol, sonicate to de-gas for 15 min, and obtain. Store at room temperature, valid for 7 days.
------------------------------------------------------------------------------------
原文: 取样方法：取样前用磁力搅拌器以一定转速搅拌15 min及以上，转速设定以形成明显凹陷但不产生涡流及大量气泡为准。 从待测给药制剂的上、中、下层各取2份样，各6份样均按下表进行处理。

译文: Sampling method：Before sampling, stir with a magnetic stirrer at a certain speed for 15 min or more, with the stirring speed set to form a noticeable depression without generating vortices or a large number of bubbles. Take 2 samples from the upper, middle, and lower layers of the dose formulation to be tested, and handle 6 samples according to the table below.
------------------------------------------------------------------------------------
原文: 注：若实验中用到其它试剂，相关信息 (试剂名称、生产厂家等) 需在原始记录及总结报告中如实体现，以总结报告为准； 纯水为苏州华测生物有限公司自制，批号为接取当天日期后六位。

译文: Note：If other reagents are used in the assay, relevant information (Reagent Name, Manufacturer, etc.) must be accurately reflected in the raw record and final report, with the final report prevailing; pure water is self-produced by Suzhou Huace Biological Co., Ltd., with batch number being the last six digits of the sampling date.
------------------------------------------------------------------------------------
